Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
8
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Silverman Joshua | Executive Chairman, Director | 8 | $0 | $0 | 2026-10-01 |
| Voss Chelsea Sierra | Director | 5 | $5.5K | $0 | 2026-04-13 |
| Friscia Stephen | Director | 3 | $0 | $0 | 2026-04-13 |
| Glass Mitchell | Director, Chief Medical Off. | 3 | $0 | $0 | 2026-04-13 |
| Bernstein Bruce | Director | 2 | $0 | $0 | 2026-04-13 |
| White Billy Joe | Director | 3 | $0 | $0 | 2026-04-13 |
| RAUCH GARY M | Other | 2 | $0 | $0 | 2025-11-14 |
| PharmaCyte Biotech, Inc. | 10% Owner | 2 | $0 | $0 | 2025-11-14 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Silverman Joshua | Executive Chairman, Director | A Award | 2026-10-01 | 2026-10-02 | 77,390 | — | $0 | 210,845 | SEC↗ |
| Silverman Joshua | Executive Chairman, Director | A Award | 2026-07-10 | 2026-10-02 | 16,620 | — | $0 | 133,455 | SEC↗ |
| Voss Chelsea Sierra | Director | A Award deriv | 2026-04-13 | 2026-04-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Silverman Joshua | Executive Chairman | A Award deriv | 2026-04-13 | 2026-04-15 | 100,000 | — | $0 | 50,000 | SEC↗ |
| White Billy Joe | Director | A Award deriv | 2026-04-13 | 2026-04-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Friscia Stephen | Director | A Award deriv | 2026-04-13 | 2026-04-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Glass Mitchell | Chief Medical Officer | A Award deriv | 2026-04-13 | 2026-04-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Bernstein Bruce | Director | A Award deriv | 2026-04-13 | 2026-04-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Silverman Joshua | Executive Chairman | A Award | 2026-04-13 | 2026-04-15 | 162,162 | — | $0 | 262,191 | SEC↗ |
| Silverman Joshua | Executive Chairman, Director | A Award deriv | 2026-04-13 | 2026-10-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Silverman Joshua | Executive Chairman, Director | A Award | 2026-04-13 | 2026-10-02 | 16,806 | — | $0 | 116,835 | SEC↗ |
| Voss Chelsea Sierra | Director | P Buy | 2026-03-30 | 2026-05-14 | 1,753 | $3.15 | $5.5K | 61,555 | SEC↗ |
| Voss Chelsea Sierra | Director | A Award deriv | 2026-01-16 | 2026-01-30 | 212,500 | — | $0 | 212,500 | SEC↗ |
| Voss Chelsea Sierra | Director | A Award | 2026-01-16 | 2026-01-30 | 212,500 | — | $0 | 214,900 | SEC↗ |
| Voss Chelsea Sierra | Director | A Award | 2026-01-16 | 2026-01-30 | 25,000 | — | $0 | 239,900 | SEC↗ |
| PharmaCyte Biotech, Inc. | 10% Owner | P Buy deriv | 2025-11-14 | 2025-11-18 | 889,865 | — | $0 | 889,865 | SEC↗ |
| RAUCH GARY M | Other | A Award | 2025-11-14 | 2025-11-14 | 11,420 | — | $0 | 12,500 | SEC↗ |
| Bernstein Bruce | Director | A Award | 2025-11-14 | 2025-11-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Friscia Stephen | Director | A Award | 2025-11-14 | 2025-11-14 | 22,839 | — | $0 | 25,000 | SEC↗ |
| Silverman Joshua | Executive Chairman | A Award | 2025-11-14 | 2025-11-14 | 91,356 | — | $0 | 100,029 | SEC↗ |
| White Billy Joe | Director | A Award | 2025-11-14 | 2025-11-17 | 22,839 | — | $0 | 25,024 | SEC↗ |
| Glass Mitchell | Director, Chief Medical Off. | A Award | 2025-11-14 | 2025-11-17 | 11,420 | — | $0 | 12,500 | SEC↗ |
| Friscia Stephen | Director | A Award | 2025-10-03 | 2025-10-06 | 2,161 | — | $0 | 2,161 | SEC↗ |
| Glass Mitchell | Director, Chief Medical Off. | A Award | 2025-10-03 | 2025-10-06 | 1,080 | — | $0 | 1,080 | SEC↗ |
| Silverman Joshua | Executive Chairman | A Award | 2025-10-03 | 2025-10-06 | 8,644 | — | $0 | 8,673 | SEC↗ |
| RAUCH GARY M | Other | A Award | 2025-10-03 | 2025-10-06 | 1,080 | — | $0 | 1,080 | SEC↗ |
| White Billy Joe | Director | A Award | 2025-10-03 | 2025-10-06 | 2,161 | — | $0 | 2,185 | SEC↗ |
| PharmaCyte Biotech, Inc. | 10% Owner | P Buy deriv | 2025-09-04 | 2025-11-18 | 889,865 | — | $0 | 889,865 | SEC↗ |